European Heart Journal,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 25, 2024
Vascular
smooth
muscle
cell
(VSMC)
phenotype
switching
is
a
pathological
hallmark
in
various
cardiovascular
diseases.
N4-acetylcytidine
(ac4C)
catalyzed
by
N-acetyltransferase
10
(NAT10)
well
conserved
the
enzymatic
modification
of
ribonucleic
acid
(RNA).
NAT10-mediated
ac4C
acetylation
involved
physiological
and
processes,
including
cardiac
remodelling.
However,
biological
functions
underlying
regulatory
mechanisms
mRNA
modifications
vascular
diseases
remain
elusive.
Biomaterials Research,
Journal Year:
2023,
Volume and Issue:
27(1)
Published: Feb. 9, 2023
With
the
great
success
of
coronavirus
disease
(COVID-19)
messenger
ribonucleic
acid
(mRNA)
vaccines,
mRNA
therapeutics
have
gained
significant
momentum
for
prevention
and
treatment
various
refractory
diseases.
To
function
efficiently
in
vivo
overcome
clinical
limitations,
demands
safe
stable
vectors
a
reasonable
administration
route,
bypassing
multiple
biological
barriers
achieving
organ-specific
targeted
delivery
mRNA.
Nanoparticle
(NP)-based
systems
representing
leading
vector
approaches
ensure
successful
intracellular
to
target
organ.
In
this
review,
chemical
modifications
types
advanced
NPs,
including
lipid
NPs
polymers
are
summarized.
The
importance
passive
targeting,
especially
endogenous
active
targeting
nano-delivery
is
emphasized,
different
cellular
endocytic
mechanisms
discussed.
Most
importantly,
based
on
above
content
physiological
structure
characteristics
organs
vivo,
design
strategies
cells
classified
Furthermore,
influence
routes
highlighted.
Finally,
an
outlook
remaining
challenges
future
development
toward
therapies
precision
medicine
provided.
Oncogene,
Journal Year:
2024,
Volume and Issue:
43(9), P. 624 - 635
Published: Jan. 5, 2024
Abstract
Hepatocellular
carcinoma
(HCC)
is
one
of
the
leading
contributors
to
cancer-related
mortality
worldwide.
Nop2/Sun
domain
family
member
5
(NSUN5),
a
conserved
RNA
5-methylcytosine
methyltransferase,
conventionally
recognized
as
oncogenic.
However,
its
role
in
HCC
development
remains
unknown.
In
this
study,
we
observed
remarkable
upregulation
NSUN5
expression
both
tumor
tissues
from
patients
with
HCC,
establishing
correlation
unfavorable
clinical
outcomes.
knockdown
and
overexpression
significantly
inhibited
promoted
cell
proliferation,
respectively.
Additionally,
employing
combination
methylated
immunoprecipitation
sequencing
(MeRIP-seq)
RIP-seq
techniques,
identified
zinc
finger
BED
domain-containing
protein
3
(ZBED3)
novel
downstream
target
NSUN5.
found
that
ZBED3
counteracted
tumor-suppressing
effect
simultaneously
reversed
inhibition
Wnt/β-catenin
signaling
pathway.
summary,
elucidated
oncogenic
ZBED3/Wnt/β-catenin
pathway
target.
This
study
provides
therapeutic
for
further
treatment.